Cargando…
Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety
BACKGROUND: All drug marketing authorization holders have the legal obligation to collect data on the use of the products they market and to keep the labels of those products updated. As demonstrated by previous studies, many generic products have labels that are discrepant from the labels of their...
Autores principales: | Thoenes, Alexandra, Cariolato, Luca, Spierings, Julian, Pinçon, Alexis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221040/ https://www.ncbi.nlm.nih.gov/pubmed/32323200 http://dx.doi.org/10.1007/s40801-020-00187-7 |
Ejemplares similares
-
Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations
por: Samara, Chrysanthi, et al.
Publicado: (2023) -
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®
por: Gasser, Urs E, et al.
Publicado: (2013) -
Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
por: Al Ali, Lamia, et al.
Publicado: (2022) -
Managing robotics in the generic
pharmaceutical arena
por: Scheffler, Marianne
Publicado: (1992) -
New Product Development in the Pharmaceutical Industry: Evidence from a generic market
por: Yousefi, Nazila, et al.
Publicado: (2017)